127 related articles for article (PubMed ID: 32740907)
1. Community-based genetic study of Parkinson's disease in Estonia.
Muldmaa M; Mencacci NE; Pittman A; Kadastik-Eerme L; Sikk K; Taba P; Hardy J; Kõks S
Acta Neurol Scand; 2021 Jan; 143(1):89-95. PubMed ID: 32740907
[TBL] [Abstract][Full Text] [Related]
2. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.
Nichols WC; Pankratz N; Marek DK; Pauciulo MW; Elsaesser VE; Halter CA; Rudolph A; Wojcieszek J; Pfeiffer RF; Foroud T;
Neurology; 2009 Jan; 72(4):310-6. PubMed ID: 18987351
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic analysis of Vietnamese patients diagnosed with early-onset Parkinson's disease.
Do MD; Tran TN; Luong AB; Le LHG; Van Le T; Le KT; Van Vo NT; Le TN; Vu HA; Mai TP
Brain Behav; 2023 Apr; 13(4):e2950. PubMed ID: 36879366
[TBL] [Abstract][Full Text] [Related]
4. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
[TBL] [Abstract][Full Text] [Related]
6. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
[TBL] [Abstract][Full Text] [Related]
7. The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
Berge-Seidl V; Pihlstrøm L; Maple-Grødem J; Forsgren L; Linder J; Larsen JP; Tysnes OB; Toft M
Neurosci Lett; 2017 Sep; 658():48-52. PubMed ID: 28830825
[TBL] [Abstract][Full Text] [Related]
8. Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations.
Yahalom G; Greenbaum L; Israeli-Korn S; Fay-Karmon T; Livneh V; Ruskey JA; Roncière L; Alam A; Gan-Or Z; Hassin-Baer S
Parkinsonism Relat Disord; 2019 May; 62():179-184. PubMed ID: 30573413
[TBL] [Abstract][Full Text] [Related]
9. Mutation Analysis of the Genes Associated with Parkinson's Disease in a Finnish Cohort of Early-Onset Dementia.
Luukkainen L; Huttula S; Väyrynen H; Helisalmi S; Kytövuori L; Haapasalo A; Hiltunen M; Remes AM; Krüger J
J Alzheimers Dis; 2020; 76(3):955-965. PubMed ID: 32568194
[TBL] [Abstract][Full Text] [Related]
10. Targeted next-generation sequencing identifies novel variants in candidate genes for Parkinson's disease in Black South African and Nigerian patients.
Oluwole OG; Kuivaniemi H; Abrahams S; Haylett WL; Vorster AA; van Heerden CJ; Kenyon CP; Tabb DL; Fawale MB; Sunmonu TA; Ajose A; Olaogun MO; Rossouw AC; van Hillegondsberg LS; Carr J; Ross OA; Komolafe MA; Tromp G; Bardien S
BMC Med Genet; 2020 Feb; 21(1):23. PubMed ID: 32019516
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
[TBL] [Abstract][Full Text] [Related]
13. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
[TBL] [Abstract][Full Text] [Related]
15. A rapid and low-cost test for screening the most common Parkinson's disease-related GBA variants.
Straniero L; Rimoldi V; Melistaccio G; Di Fonzo A; Pezzoli G; Duga S; Asselta R
Parkinsonism Relat Disord; 2020 Nov; 80():138-141. PubMed ID: 32987361
[TBL] [Abstract][Full Text] [Related]
16. Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing Panels.
Gorostidi A; Martí-Massó JF; Bergareche A; Rodríguez-Oroz MC; López de Munain A; Ruiz-Martínez J
Mol Diagn Ther; 2016 Oct; 20(5):481-91. PubMed ID: 27294386
[TBL] [Abstract][Full Text] [Related]
17. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
[TBL] [Abstract][Full Text] [Related]
18. Genetic Analysis of ZNF Protein Family Members for Early-Onset Parkinson's Disease in Chinese Population.
Li CY; Ou RW; Chen YP; Gu XJ; Wei QQ; Cao B; Zhang LY; Hou YB; Liu KC; Chen XP; Song W; Zhao B; Wu Y; Liu Y; Shang HF
Mol Neurobiol; 2021 Jul; 58(7):3435-3442. PubMed ID: 33723766
[TBL] [Abstract][Full Text] [Related]
19. Genetic Analysis of Prosaposin, the Lysosomal Storage Disorder Gene in Parkinson's Disease.
Chen YP; Gu XJ; Ou RW; Zhang LY; Hou YB; Liu KC; Cao B; Wei QQ; Song W; Zhao B; Wu Y; Cheng JQ; Shang HF
Mol Neurobiol; 2021 Apr; 58(4):1583-1592. PubMed ID: 33219486
[TBL] [Abstract][Full Text] [Related]
20. DNAJC13 mutation screening in patients with Parkinson's disease from South Italy.
Gagliardi M; Annesi G; Procopio R; Morelli M; Iannello G; Bonapace G; Mancini M; Nicoletti G; Quattrone A
Parkinsonism Relat Disord; 2018 Oct; 55():134-137. PubMed ID: 29887357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
